Literature DB >> 9684143

Long-term results of endoscopic treatment of biliary duct obstruction due to pancreatic disease.

P Born1, T Rosch, K Bruhl, K Ulm, W Sandschin, E Frimberger, H Allescher, M Classen.   

Abstract

BACKGROUND/AIMS: Endoscopic stenting has become an established method of providing palliative treatment in cases of malignant biliary obstruction, as well as in benign biliary stenosis. Several problems associated with the types of stent used have not yet been resolved, and an ideal stent has yet to be designed. Observation of the clinical course for patients with biliary obstruction of various etiologies, and evaluation of the results with various treatment methods are the aims of this study.
METHODOLOGY: In 1993 and 1994, biliary obstruction was treated endoscopically in 47 patients with a malignant pancreatic tumor and in 18 patients with chronic pancreatitis. The primary intervention was assessed retrospectively on the basis of the patients' records, and information concerning the clinical course was obtained by contacting the patients or their relatives or general practitioners.
RESULTS: Primary endoscopic drainage was successful in all cases. Only one of the patients with pancreatic tumors is still alive; survival after stent placement averaged 6.2 months. Metal stents remained patent significantly longer than plastic stents and percutaneous transhepatic biliary drains (PTBDs)(8.2 versus 3.5 or 1.9 months; p < 0.001). In cases of chronic pancreatitis, three of the nine patients who received only endoscopic treatment, without stenting, were able to continue without stents in the longer term, whereas seven of the nine who underwent surgery had no further problems.
CONCLUSIONS: Endoscopic drainage of biliary obstruction provides excellent short-term results. In long-term treatment for purely palliative purposes, metal stents remain patent for longer than plastic stents. In chronic pancreatitis, surgical treatment clearly seems to provide better long-term results than endoscopic therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9684143

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

1.  Unresectable pancreatic adenocarcinoma: do we know who survives?

Authors:  Mohammad H Jamal; Suhail A Doi; Eve Simoneau; Jad Abou Khalil; Mazen Hassanain; Prosanto Chaudhury; Jean Tchervenkov; Peter Metrakos; Jeffrey S Barkun
Journal:  HPB (Oxford)       Date:  2010-10       Impact factor: 3.647

Review 2.  Systematic appraisal of the role of metallic endobiliary stents in the treatment of benign bile duct stricture.

Authors:  H P Priyantha Siriwardana; Ajith K Siriwardena
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

3.  Pancreaticoduodenectomy for periampullary malignancies: the effect of bile colonization on the postoperative outcome.

Authors:  Alberto M Isla; John Griniatsos; Ali Riaz; Evangelos Karvounis; Robin C N Williamson
Journal:  Langenbecks Arch Surg       Date:  2006-11-07       Impact factor: 3.445

4.  Biliary tract obstruction in chronic pancreatitis.

Authors:  Abdul A Abdallah; Jake E J Krige; Philippus C Bornman
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 5.  Chronic pancreatitis: modern surgical management.

Authors:  Kai Bachmann; Jakob R Izbicki; Emre F Yekebas
Journal:  Langenbecks Arch Surg       Date:  2010-12-21       Impact factor: 3.445

6.  Percutaneous imaging-guided interventions for acute biliary disorders in high surgical risk patients.

Authors:  Ragab Hani Donkol; Nahed Abdel Latif; Khaled Moghazy
Journal:  World J Radiol       Date:  2010-09-28

Review 7.  Endoscopic retrograde cholangiopancreatography in the diagnosis and management of pancreatic diseases.

Authors:  R J Shah; S P Martin
Journal:  Curr Gastroenterol Rep       Date:  2000-04

Review 8.  Endoscopic therapy in chronic pancreatitis: current perspectives.

Authors:  Andrada Seicean; Simona Vultur
Journal:  Clin Exp Gastroenterol       Date:  2014-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.